Impact of Age and Gender on Survival of Glioblastoma Multiforme Patients: A Multicenter Retrospective Study

Overview

Journal Cancer Rep (Hoboken)

Specialty Oncology

Date 2024 Nov 7

PMID 39506810

Authors

Zoheir Reihanian

Elahe Abbaspour

Nooshin Zaresharifi

Sahand Karimzadhagh

Maral Mahmoudalinejad

Ainaz Sourati

Mohaya Farzin

Habib EslamiKenarsari

Affiliations

Soon will be listed here.

Abstract

Background: Glioblastoma multiforme (GBM) poses a significant health challenge as the most common primary malignancy of the adult central nervous system. Gender- and age-related differences in GBM influence prognosis and treatment complexities. This multicenter retrospective study explores gender and age disparities in GBM patients, investigating their impact on occurrence and survival outcomes.

Methods: This multicenter retrospective study involved GBM patients treated in Guilan Province, Iran. Patients' data, including age, gender, tumor location, and histopathological diagnosis date, was collected from medical records.

Results: In a cohort of 164 GBM patients, the average age was 54.34 ± 14.16 years, with a higher prevalence among men (59.8%) and patients aged ≤ 60 years (64.6%). The tumor sites exhibited overlapping features in 68% of cases, with the frontal and temporal lobes being the most common specific locations. The mean survival was 12.88 ± 14.14 months, one-year survival of 45%, with women showing significantly higher one-year survival (60% vs. 40%) and longer mean survival (16.14 ± 17.35 vs. 10.75 ± 11.15 months). Furthermore, Patients ≤ 60 years had significantly higher one-year survival (75% vs. 35%). In subgroup analysis, women had significantly higher survival rates in patients ≤ 60 years. However, among patients over 60, women exhibited a more pronounced decline in survival rates, with no statistically significant difference between men and women in this age group.

Conclusion: This study highlights that both age and gender significantly affect GBM survival outcomes. Younger patients, particularly women, exhibited better survival rates, while older patients, especially women, showed poorer outcomes. These findings suggest the need to stratify treatment approaches by both age and gender to optimize care and improve survival in GBM patients. Further research is recommended to explore these associations.

References

Zhong Y, He K, Shi L, Chen L, Zhou B, Ma R . Down-regulation of estrogen-related receptor alpha (ERRα) inhibits gastric cancer cell migration and invasion and . Aging (Albany NY). 2021; 13(4):5845-5857. PMC: 7950300. DOI: 10.18632/aging.202508. View

Chen B, Chen C, Zhang Y, Xu J . Recent incidence trend of elderly patients with glioblastoma in the United States, 2000-2017. BMC Cancer. 2021; 21(1):54. PMC: 7802341. DOI: 10.1186/s12885-020-07778-1. View

Tian M, Ma W, Chen Y, Yu Y, Zhu D, Shi J . Impact of gender on the survival of patients with glioblastoma. Biosci Rep. 2018; 38(6). PMC: 6239255. DOI: 10.1042/BSR20180752. View

Sturm D, Bender S, Jones D, Lichter P, Grill J, Becher O . Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat Rev Cancer. 2014; 14(2):92-107. PMC: 4003223. DOI: 10.1038/nrc3655. View

Bonosi L, Marrone S, Benigno U, Buscemi F, Musso S, Porzio M . Maximal Safe Resection in Glioblastoma Surgery: A Systematic Review of Advanced Intraoperative Image-Guided Techniques. Brain Sci. 2023; 13(2). PMC: 9954589. DOI: 10.3390/brainsci13020216. View

Sun T, Warrington N, Luo J, Brooks M, Dahiya S, Snyder S . Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males. J Clin Invest. 2014; 124(9):4123-33. PMC: 4151215. DOI: 10.1172/JCI71048. View

Brodbelt A, Greenberg D, Winters T, Williams M, Vernon S, Collins V . Glioblastoma in England: 2007-2011. Eur J Cancer. 2015; 51(4):533-542. DOI: 10.1016/j.ejca.2014.12.014. View

Chahal M, Thiessen B, Mariano C . Treatment of Older Adult Patients with Glioblastoma: Moving towards the Inclusion of a Comprehensive Geriatric Assessment for Guiding Management. Curr Oncol. 2022; 29(1):360-376. PMC: 8774312. DOI: 10.3390/curroncol29010032. View

Wu F, Chai R, Wang Z, Liu Y, Zhao Z, Li G . Molecular classification of IDH-mutant glioblastomas based on gene expression profiles. Carcinogenesis. 2019; 40(7):853-860. PMC: 6642368. DOI: 10.1093/carcin/bgz032. View

10.

Singh N, Miner A, Hennis L, Mittal S . Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review. Cancer Drug Resist. 2021; 4:17-43. PMC: 8319838. DOI: 10.20517/cdr.2020.79. View

11.

Boltman T, Meyer M, Ekpo O . Diagnostic and Therapeutic Approaches for Glioblastoma and Neuroblastoma Cancers Using Chlorotoxin Nanoparticles. Cancers (Basel). 2023; 15(13). PMC: 10341066. DOI: 10.3390/cancers15133388. View

12.

Honikl L, Lammer F, Gempt J, Meyer B, Schlegel J, Delbridge C . High expression of estrogen receptor alpha and aromatase in glial tumor cells is associated with gender-independent survival benefits in glioblastoma patients. J Neurooncol. 2020; 147(3):567-575. PMC: 7256026. DOI: 10.1007/s11060-020-03467-y. View

13.

Yang W, Warrington N, Taylor S, Whitmire P, Carrasco E, Singleton K . Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data. Sci Transl Med. 2019; 11(473). PMC: 6502224. DOI: 10.1126/scitranslmed.aao5253. View

14.

Ius T, Sabatino G, Panciani P, Fontanella M, Ruda R, Castellano A . Surgical management of Glioma Grade 4: technical update from the neuro-oncology section of the Italian Society of Neurosurgery (SINch®): a systematic review. J Neurooncol. 2023; 162(2):267-293. PMC: 10167129. DOI: 10.1007/s11060-023-04274-x. View

15.

Carrano A, Juarez J, Incontri D, Ibarra A, Guerrero Cazares H . Sex-Specific Differences in Glioblastoma. Cells. 2021; 10(7). PMC: 8303471. DOI: 10.3390/cells10071783. View

16.

Serban G, Tamas F, Balasa R, Manu D, Tamas C, Balasa A . Prognostic Factors of Survival in Glioblastoma Multiforme Patients-A Retrospective Study. Diagnostics (Basel). 2022; 12(11). PMC: 9689032. DOI: 10.3390/diagnostics12112630. View

17.

Hanif F, Muzaffar K, Perveen K, Malhi S, Simjee S . Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment. Asian Pac J Cancer Prev. 2017; 18(1):3-9. PMC: 5563115. DOI: 10.22034/APJCP.2017.18.1.3. View

18.

Bello-Alvarez C, Camacho-Arroyo I . Impact of sex in the prevalence and progression of glioblastomas: the role of gonadal steroid hormones. Biol Sex Differ. 2021; 12(1):28. PMC: 7986260. DOI: 10.1186/s13293-021-00372-5. View

19.

Zhang L, Zhu Y, Cheng H, Zhang J, Zhu Y, Chen H . The Increased Expression of Estrogen-Related Receptor α Correlates with Wnt5a and Poor Prognosis in Patients with Glioma. Mol Cancer Ther. 2018; 18(1):173-184. DOI: 10.1158/1535-7163.MCT-17-0782. View

20.

Vomer 2nd R, Narducci D, Larick R, York E, Terry K . Strike Out: A Case Report of Glioblastoma in a Collegiate Softball Player. Cureus. 2023; 15(8):e44486. PMC: 10544434. DOI: 10.7759/cureus.44486. View